AIMS/HYPOTHESIS: Insulin effects reportedly involve reactive oxygen species (ROS) and oxidative stress in vitro, but skeletal muscle oxidative stress is an emerging negative regulator of insulin action following high-fat feeding. NEFA may enhance oxidative stress and insulin resistance. We investigated the acute impact of insulin with or without NEFA elevation on muscle ROS generation and insulin signalling, and the potential association with altered muscle mitochondrial function. METHODS: We used hyperinsulinaemic-euglycaemic clamping, 150 min, without or with lipid infusion to modulate plasma NEFA concentration in lean rats. RESULTS: Insulin and glucose (Ins) infusion selectively enhanced xanthine oxidase-dependent muscle ROS generation. Ins with lipid infusion (Ins+NEFA) lowered whole-body glucose disposal and muscle insulin signalling, and these effects were associated with high muscle mitochondrial ROS generation and activation of the proinflammatory nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) pathway. Antioxidant infusion prevented NEFA-induced systemic insulin resistance and changes in muscle mitochondrial ROS generation, IκB-NFκB pathway and insulin signalling. Changes in insulin sensitivity and signalling were independent of changes in mitochondrial enzyme activity and ATP production, which, in turn, were not impaired by changes in ROS generation under any condition. CONCLUSIONS/ INTERPRETATION: Acute muscle insulin effects include enhanced ROS generation through xanthine oxidase. Additional NEFA elevation enhances mitochondrial ROS generation, activates IκB-NFκB and reduces insulin signalling. These alterations are not associated with acute reductions in mitochondrial enzyme activity and ATP production, and are reversed by antioxidant infusion. Thus, NEFA acutely cause systemic and muscle insulin resistance by enhancing muscle oxidative stress through mitochondrial ROS generation and IκB-NFκB activation.
AIMS/HYPOTHESIS: Insulin effects reportedly involve reactive oxygen species (ROS) and oxidative stress in vitro, but skeletal muscle oxidative stress is an emerging negative regulator of insulin action following high-fat feeding. NEFA may enhance oxidative stress and insulin resistance. We investigated the acute impact of insulin with or without NEFA elevation on muscle ROS generation and insulin signalling, and the potential association with altered muscle mitochondrial function. METHODS: We used hyperinsulinaemic-euglycaemic clamping, 150 min, without or with lipid infusion to modulate plasma NEFA concentration in lean rats. RESULTS: Insulin and glucose (Ins) infusion selectively enhanced xanthine oxidase-dependent muscle ROS generation. Ins with lipid infusion (Ins+NEFA) lowered whole-body glucose disposal and muscle insulin signalling, and these effects were associated with high muscle mitochondrial ROS generation and activation of the proinflammatory nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) pathway. Antioxidant infusion prevented NEFA-induced systemic insulin resistance and changes in muscle mitochondrial ROS generation, IκB-NFκB pathway and insulin signalling. Changes in insulin sensitivity and signalling were independent of changes in mitochondrial enzyme activity and ATP production, which, in turn, were not impaired by changes in ROS generation under any condition. CONCLUSIONS/ INTERPRETATION: Acute muscle insulin effects include enhanced ROS generation through xanthine oxidase. Additional NEFA elevation enhances mitochondrial ROS generation, activates IκB-NFκB and reduces insulin signalling. These alterations are not associated with acute reductions in mitochondrial enzyme activity and ATP production, and are reversed by antioxidant infusion. Thus, NEFA acutely cause systemic and muscle insulin resistance by enhancing muscle oxidative stress through mitochondrial ROS generation and IκB-NFκB activation.
Authors: Yongzhong Wei; James R Sowers; Suzanne E Clark; Wenhan Li; Carlos M Ferrario; Craig S Stump Journal: Am J Physiol Endocrinol Metab Date: 2007-12-11 Impact factor: 4.310
Authors: Kim Loh; Haiyang Deng; Atsushi Fukushima; Xiaochu Cai; Benoit Boivin; Sandra Galic; Clinton Bruce; Benjamin J Shields; Beata Skiba; Lisa M Ooms; Nigel Stepto; Ben Wu; Christina A Mitchell; Nicholas K Tonks; Matthew J Watt; Mark A Febbraio; Peter J Crack; Sofianos Andrikopoulos; Tony Tiganis Journal: Cell Metab Date: 2009-10 Impact factor: 27.287
Authors: C Andrew Haber; Tony K T Lam; Zhiwen Yu; Neehar Gupta; Tracy Goh; Elena Bogdanovic; Adria Giacca; I George Fantus Journal: Am J Physiol Endocrinol Metab Date: 2003-06-10 Impact factor: 4.310
Authors: Natalie Lefort; Brian Glancy; Benjamin Bowen; Wayne T Willis; Zachary Bailowitz; Elena A De Filippis; Colleen Brophy; Christian Meyer; Kurt Højlund; Zhengping Yi; Lawrence J Mandarino Journal: Diabetes Date: 2010-08-03 Impact factor: 9.461
Authors: S Paglialunga; B van Bree; M Bosma; M P Valdecantos; E Amengual-Cladera; J A Jörgensen; D van Beurden; G J M den Hartog; D M Ouwens; J J Briedé; P Schrauwen; J Hoeks Journal: Diabetologia Date: 2012-07-12 Impact factor: 10.122
Authors: Sandra Pereira; Edward Park; Yusaku Mori; C Andrew Haber; Ping Han; Toyoyoshi Uchida; Laura Stavar; Andrei I Oprescu; Khajag Koulajian; Alexander Ivovic; Zhiwen Yu; Deling Li; Thomas A Bowman; Jay Dewald; Jamel El-Benna; David N Brindley; Roger Gutierrez-Juarez; Tony K T Lam; Sonia M Najjar; Robert A McKay; Sanjay Bhanot; I George Fantus; Adria Giacca Journal: Am J Physiol Endocrinol Metab Date: 2014-05-13 Impact factor: 4.310